Cheng, Matthew E.
Janzekovic, Jan
Theile, Harrison J.
Rutherford-Heard, Caitlin
Wille, Marie-Luise
Cole, Chris
Lloyd, Thomas B.
Theile, Richard J. W.
Wagels, Michael
Hutmacher, Dietmar W.
Article History
Received: 2 August 2021
Accepted: 19 October 2021
First Online: 19 November 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This case was reviewed by our institution’s clinical ethics committee where it was agreed that offering the patient an experimental treatment was acceptable (Approval number: HREC/2021/QMS/69789).
: The patient gave written consent regarding publishing her data and photographs.
: Dietmar W. Hutmacher is a founder and shareholder of BellaSeno GmbH. Matthew E. Cheng, Jan Janzekovic, Harrison J. Theile, Caitlin Rutherford Heard, Marie Luise Wille, Chris Cole, Thomas B. Lloyd, Richard J. W. Theile and Michael Wagels declare that they have no conflict of interest.